Live updates


350 Boots jobs will go at Nottingham head office

Credit: PA

It's been confirmed that half of the 700 jobs going at Boots will go at the Nottingham head office and will include support and admin staff.

The Nottingham-based company says it is trying to simplify its structure across roles outside of the stores. Talks will begin with affected staff in due course.

The firm has said that more jobs may be created in its digital unit.

The announcement comes months after the merger between Boots and US pharmacy group Walgreens.

700 jobs to go at Boots

Credit: Anna Gowthorpe/PA Archive/Press Association Images

700 jobs are to go at Boots, the company has announced this morning.

It's reported that half the job losses will be at the Beeston head office.

The job losses will be achieved through redundancy, retraining and redeployment.

Talks are due to begin with affected members of staff.

The company claims they are restructuring to provide a better standard of service for customers and to ensure future growth and that they are "committed" to their presence in Nottingham.

Together with my leadership team, I believe this plan will make Boots even better for our customers and drive sustainable future growth. We also remain fully committed to our presence in Nottingham, which has been the home of Boots since the very beginning.

– Simon Roberts, Boots President

Boots expects 'no job losses' ahead of Walgreens takeover

No job losses are expected at Nottingham-based Boots Credit: PA Wire

Nottingham-based Boots says no job losses are expected ahead of the full takeover of the company by American drug-store giants Walgreens.

Walgreens, which also trades as Duane Reade, is set to spend around £5 billion on the outstanding 55% stake in Alliance Boots.

Given the complementary geographic footprints of Walgreens and Alliance Boots, job reductions are not expected at either company as a result of the merger.

Nottingham is at the heart of the Boots heritage (it has been the home of Boots for over 160 years) and it will continue to be a very important hub in the future within the global enterprise.

Nottingham is a key site for our activities in pharmacy, retailing, R&D, product manufacturing and pharmaceutical wholesale.

We firmly believe that our employees will benefit from being part of an even stronger and much larger organisation, and that this merger is a vital step in achieving our vision of becoming a global healthcare leader and Boots, our principal retail brand, will play a pivotal role.

– Alliance Boots spokesperson


Boots subject to full takeover by Walgreens, say reports

An announcement is expected tomorrow over Boots' future Credit: PA

Reports suggest the Nottingham-based high street chemist Boots could be subject to a full takeover by American drug-store giants Walgreens.

According to Sky news, Walgreens plan to acquire the remaining 55 per cent that it doesn't already own in a deal costing more than five billion pounds.

They are expected to make an announcement tomorrow, with speculation they'll keep their headquarters in America.

Boots, which was founded by Jesse Boot in the 1870's, sold almost half its shares to Walgreen in a multi-billion pound cash and shares deal back in 2012, making the firm part of the world's biggest pharmacy chain.

Boots: 'Health and safety of customers is always our highest priority'

Boots has recalled some of its cough and cold medicines over fears that plastic might have got into the liquid.

The health and safety of our customers and patients is always our highest priority so as a precaution we are recalling some Boots Pharmaceuticals medicine lines.

Whilst we're not currently aware of any customer incidences, we have taken the decision to ask customers to return these products to our stores for a refund.

We're sorry for any inconvenience this may cause our customers and would like to offer our reassurances that these actions are taken as a precaution, while we fully investigate the situation.

– Boots

Boots recalls cough and cold medicines

Boots has recalled some of its cough and cold medicines over fears that plastic might have got into the liquid.

The pharmacy company, based in Nottingham, said it identified a possible fault in the manufacturing process of the tamper seal which might result in small pieces of plastic getting into the solutions.

A Boots store Credit: Anna Gowthorpe/PA

The Medicines and Healthcare products Regulatory Agency (MHRA) published the company-led recall for medicines purchased since September.

There is "currently no evidence" of any problems among people who have taken the medicines, MHRA said.

  1. National

Shoppers asked to return some cold medicines to Boots

Shoppers are being asked to return the medicine to Boots as a precautionary measure, where they will get a refund.

Anyone with questions can telephone the Boots Customer Care Line on 0800 915 0004, or contact the healthcare team at their local Boots store.

The medicines are:

  • Boots Pharmaceuticals Paracetamol 6 years Plus (250mg/5ml oral solution 200ml)
  • Boots Pharmaceuticals Ibuprofen 3 Months Plus (100mg/5ml oral suspension, strawberry flavour)
  • Boots Pharmaceuticals Chesty Cough Relief (100mg/5ml oral solution)
  • Boots Pharmaceuticals Dry Cough Relief oral solution
  • Boots Pharmaceuticals Mucus Cough Relief (100mg/5ml oral solution)
Load more updates